On May 6, the New Jersey Attorney General, Gurbir S. Grewal, finalized and made effective amendments to the rules governing physician interactions with pharmaceutical companies (“Limitations on and Obligations Associated with Prescriber Acceptance of Compensation from Pharmaceutical Manufacturers”). Originally proposed in August 2018, the finalized amendments reflect the 69 comments the Attorney General received and address, among other things, the scope of the rules, meal limits, the $10,000 bona fide services cap, and changes to definitions such as “education event,” “prescriber,” and “research.”
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,